Stansberry Asset Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-115,638
| Closed | -$9.19M | – | 61 |
|
|
2019
Q4 | $9.19M | Sell |
115,638
-3,734
| -3% | -$297K | 3.74% | 7 |
|
|
2019
Q3 | $5.79M | Buy |
119,372
+4,810
| +4% | +$233K | 2.56% | 15 |
|
|
2019
Q2 | $6.03M | Sell |
114,562
-6,032
| -5% | -$317K | 2.37% | 14 |
|
|
2019
Q1 | $6.38M | Buy |
120,594
+43,695
| +57% | +$2.31M | 2.19% | 13 |
|
|
2018
Q4 | $3.16M | Sell |
76,899
-7,680
| -9% | -$315K | 0.99% | 19 |
|
|
2018
Q3 | $3.21M | Sell |
84,579
-34,196
| -29% | -$1.3M | 0.9% | 34 |
|
|
2018
Q2 | $5.37M | Buy |
118,775
+67,363
| +131% | +$3.05M | 1.78% | 19 |
|
|
2018
Q1 | $2.48M | Buy |
51,412
+111
| +0.2% | +$5.36K | 1.22% | 30 |
|
|
2017
Q4 | $2.02M | Buy |
+51,301
| New | +$2.02M | 0.87% | 33 |
|